Ni Jie, Ye Aili, Gong Liya, Zhao Xiafei, Fu Sisi, Guo Jieya
Department of Endocrinology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, Zhejiang 311202, China.
Nutr Res Pract. 2024 Aug;18(4):479-497. doi: 10.4162/nrp.2024.18.4.479. Epub 2024 May 23.
BACKGROUND/OBJECTIVES: Activating brown adipose tissue (BAT) and browning of white adipose tissue (WAT) can protect against obesity and obesity-related metabolic conditions. Cryptotanshinone (CT) regulates lipid metabolism and significantly ameliorates insulin resistance. Adenosine-5'-monophosphate (AMP)-activated protein kinase (AMPK), a receptor for cellular energy metabolism, is believed to regulate brown fat activity in humans.
MATERIALS/METHODS: The study included high-fat-fed obese mice administered orally 200/400 mg/kg/d CT. They were evaluated through weight measurement, the intraperitoneal glucose tolerance test (IPGTT), intraperitoneal insulin tolerance test (IPITT), cold stimulation test, serum lipid (total cholesterol, triglycerides, and low-density lipoprotein) measurement, hematoxylin and eosin staining, and immunohistochemistry. Furthermore, the study investigated primary adipose mesenchymal stem cells (MSCs) with incubation of CT and AMPK agonists (acadesine)/inhibitor (Compound C). Cells were evaluated using Oil Red O staining, Alizarin red staining, flow cytometry, and immunofluorescence staining to identify and observe the osteogenic versus adipogenic differentiation. Quantitative real-time polymerase chain reaction and the Western blot were used to observe related gene expression.
In the diet-induced obesity mouse model mice CT suppressed body weight, food intake, glucose levels in the IPGTT and IPTT, serum lipids, the volume of adipose tissue, and increased thermogenesis, uncoupling protein 1, and the AMPK pathway expression. In the study, CT prevented the formation of lipid droplets from MSCs while activating brown genes and the AMPK pathway. AMPK activator enhanced CT's effects, while the AMPK inhibitor reversed the effects of CT.
CT promotes adipose tissue browning to increase body thermogenesis and reduce obesity by activating the AMPK pathway. This study provides an experimental foundation for the use of CT in obesity treatment.
背景/目的:激活棕色脂肪组织(BAT)以及白色脂肪组织(WAT)的褐色化可预防肥胖及肥胖相关的代谢性疾病。隐丹参酮(CT)可调节脂质代谢并显著改善胰岛素抵抗。腺苷-5'-单磷酸(AMP)激活的蛋白激酶(AMPK)作为细胞能量代谢的感受器,被认为可调节人类棕色脂肪的活性。
材料/方法:本研究纳入了高脂喂养的肥胖小鼠,口服给予200/400 mg/kg/d的CT。通过体重测量、腹腔内葡萄糖耐量试验(IPGTT)、腹腔内胰岛素耐量试验(IPITT)、冷刺激试验、血清脂质(总胆固醇、甘油三酯和低密度脂蛋白)测量、苏木精-伊红染色及免疫组织化学对其进行评估。此外,本研究还对原代脂肪间充质干细胞(MSCs)进行了CT与AMPK激动剂(阿卡地新)/抑制剂(化合物C)孵育的研究。使用油红O染色、茜素红染色、流式细胞术及免疫荧光染色对细胞进行评估,以鉴定并观察成骨与成脂分化。采用定量实时聚合酶链反应及蛋白质免疫印迹法观察相关基因表达。
在饮食诱导的肥胖小鼠模型中,CT可抑制体重、食物摄入量、IPGTT和IPITT中的血糖水平、血清脂质、脂肪组织体积,并增加产热、解偶联蛋白1及AMPK途径的表达。在本研究中,CT可防止MSCs形成脂滴,同时激活棕色基因及AMPK途径。AMPK激活剂可增强CT的作用,而AMPK抑制剂则可逆转CT的作用。
CT通过激活AMPK途径促进脂肪组织褐色化,以增加机体产热并减轻肥胖。本研究为CT用于肥胖治疗提供了实验依据。